NeuroSense Files U.S. Patent for PrimeC TBI Treatment
NeuroSense filed a U.S. patent covering use of PrimeC’s components to treat traumatic brain injury and related CNS injuries. Protection could extend to 2047 if granted.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.